Pliant Therapeutics Inc. (PLRX) Social Stream
PLIANT THERAPEUTICS INC (PLRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PLIANT THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $63 | $45 | $52.75 | $18.26 | 188.88% |
| 2021-11-24 | 5 | $63 | $38 | $49.8 | $18.26 | 172.73% |
| 2022-03-01 | 6 | $63 | $38 | $48.166 | $18.26 | 163.78% |
| 2022-05-11 | 5 | $63 | $38 | $46.5 | $18.26 | 154.65% |
| 2022-05-18 | 5 | $45 | $27 | $37.5 | $18.26 | 105.37% |
| 2022-06-01 | 6 | $45 | $27 | $35.6 | $18.26 | 94.96% |
| 2022-07-26 | 7 | $54 | $33 | $42 | $18.26 | 130.01% |
| 2022-08-11 | 7 | $54 | $33 | $43.833 | $18.26 | 140.05% |
| 2022-09-01 | 8 | $54 | $33 | $42.714 | $18.26 | 133.92% |
| 2022-11-18 | 9 | $53 | $33 | $42.142 | $18.26 | 130.79% |
| 2022-12-07 | 9 | $53 | $33 | $42.125 | $18.26 | 130.7% |
| 2023-01-22 | 10 | $53 | $33 | $41.111 | $18.26 | 125.14% |
| 2023-01-23 | 10 | $53 | $36 | $43.777 | $18.26 | 139.74% |
| 2023-02-08 | 11 | $55 | $40 | $46.7 | $18.26 | 155.75% |
| 2023-02-13 | 11 | $55 | $40 | $47.9 | $18.26 | 162.32% |
| 2023-03-10 | 11 | $55 | $40 | $48 | $18.26 | 162.87% |
| 2023-03-15 | 11 | $58 | $40 | $47.9 | $18.26 | 162.32% |
| 2023-03-20 | 11 | $58 | $40 | $48 | $18.26 | 162.87% |
| 2023-04-20 | 12 | $58 | $40 | $47.636 | $18.26 | 160.88% |
| 2023-05-01 | 12 | $63 | $40 | $48.727 | $18.26 | 166.85% |
| 2023-05-10 | 12 | $57 | $40 | $47 | $18.26 | 157.39% |
| 2023-06-23 | 13 | $57 | $40 | $47.09 | $18.26 | 157.89% |
| 2023-06-26 | 13 | $63 | $40 | $48.416 | $18.26 | 165.15% |
| 2023-08-21 | 13 | $63 | $35 | $47.833 | $18.26 | 161.96% |
| 2023-10-16 | 13 | $63 | $35 | $48.083 | $18.26 | 163.32% |
| 2023-11-10 | 13 | $63 | $34 | $47.75 | $18.26 | 161.5% |
| 2023-12-08 | 13 | $53 | $34 | $45.333 | $18.26 | 148.26% |
The Trend in the Analyst Price Target
Over the past 22 months, PLRX's average price target has gone down $1.17.
PLRX reports an average of 119.28% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 11 | 55 | 40 | 47.900 | 31.74 | 50.91% |
| 2023-03-10 | 11 | 55 | 40 | 47.600 | 27.98 | 70.12% |
| 2023-03-10 | 11 | 55 | 40 | 48.000 | 27.98 | 71.55% |
| 2023-08-21 | 13 | 63 | 35 | 47.833 | 17.17 | 178.58% |
| 2023-09-27 | 13 | 63 | 35 | 48.083 | 16.56 | 190.36% |
PLRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.15 | 11 | 2 | 0 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 28 months, PLRX's average broker recommendation rating improved by 0.45.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PLIANT THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3393.75% of all US stocks.
- PLRX has a higher number of analysts covering the stock than 3525.75% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, PLIANT THERAPEUTICS INC's average analyst price target is greater than 3543.31% of them.
- PLIANT THERAPEUTICS INC's variance in analysts' estimates is lower than -1058.14% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, CALT, RPTX, and NRIX are the three stocks most similar to PLIANT THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PLRX a Buy, Hold or Sell? See the POWR Ratings now!